Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Silence Therapeutics Total Long Term Debt (Quarterly) : 0.009M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.009M |
| March 31, 2026 | 0.043M |
| December 31, 2025 | 0.071M |
| September 30, 2025 | 0.097M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| September 30, 2024 | 0.1864M |
| June 30, 2024 | 0.2326M |
| March 31, 2024 | 0.3499M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.3468M |
| September 30, 2023 | 0.3844M |
| June 30, 2023 | 0.4627M |
| March 31, 2023 | 0.4921M |
| December 31, 2022 | 0.5365M |
| September 30, 2022 | 0.557M |
| June 30, 2022 | 0.0632M |
| March 31, 2022 | 0.1185M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 0.00 |
| NuCana Plc | 0.892M |
| Mereo BioPharma Group Plc | 0.00 |
| Compass Pathways Plc | 52.74M |
| HemoGenyx Pharmaceuticals Plc | 0.00 |